← All indications
Adenocarcinoma, Follicular
An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)
Subtype terms (1)
More specific conditions that are subtypes of Adenocarcinoma, Follicular in the MeSH hierarchy.
Drugs by status
Approved for this indication (1)
Organizations
Organization Involved with Phase 2 Indications (21)
- Eisai
- Celgene
- Immunomedics
- Exelixis
- Pfizer
- National Cancer Institute (NCI)
- Academic and Community Cancer Research United
- Cornell University
- Emory University
- Georgetown University
- University of Washington
- Grupo Espanol de Tumores Neuroendocrinos (GETNE)
- Ohio State University
- University of Kentucky
- University of South Florida
- Mayo Clinic
- University of Chicago
- University of Texas at Houston
- National Comprehensive Cancer Network
- Memorial Sloan-Kettering Cancer Center
- Vall d'Hebron Institute of Research, Galatea Clinic
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (2)